Format

Send to

Choose Destination
J Antimicrob Chemother. 2004 Oct;54(4):818-20. Epub 2004 Sep 3.

Reversion to susceptibility in a linezolid-resistant clinical isolate of Staphylococcus aureus.

Author information

1
Division of Infectious Diseases, Beth Israel Deaconess Medical Center, Boston, MA 02115, USA. vmeka@bidmc.harvard.edu

Abstract

OBJECTIVES:

Linezolid resistance in rare isolates of Staphylococcus aureus has been associated with G2576T mutations in domain V of the 23S rRNA gene. We report the analysis of a clinical S. aureus isolate that developed linezolid resistance (MIC of linezolid of 12 mg/L) after a 25 day course of the drug. Sequencing identified G2576T mutations in four of the five copies of the 23S rRNA gene.

METHODS:

To examine the stability of this resistance, we serially passaged this original isolate 60 times over a 75 day period on antimicrobial-free medium.

RESULTS:

After 30 passages, the MIC of linezolid had decreased to 8 mg/L and only two of the five copies of the 23S rRNA gene contained the G2576T mutation. After 60 passages, the MIC of linezolid fell to 2 mg/L and only one of the five 23S rRNA gene copies contained the mutation. The original and two passaged staphylococci were indistinguishable by pulsed-field gel electrophoresis.

CONCLUSIONS:

In the absence of antibiotic pressure, linezolid resistance was unstable in a clinical isolate that did not have all copies of the 23S rRNA gene mutated, although a single copy of mutant rDNA was maintained. Gene conversion was probably the mechanism for this reversion, using the wild-type 23S rRNA gene sequences to replace the G2576T mutation by homologous recombination.

PMID:
15347637
DOI:
10.1093/jac/dkh423
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center